{"transactions":[{"id":707488,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":29916,"kind":"person","name":"Marasco Dominic","position":1,"cik":"0002053897","reported_name":"Marasco Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2026-07-18T01:47:08.000Z","date":"2026-07-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3623,"price":4.09,"value":14818.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,775 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026."}],"balance_after":343398,"source":{"system":"sec-edgar","filing":"0001193125-26-308137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000119312526308137/ownership.xml","form_type":"4"}},{"id":766817,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":29916,"kind":"person","name":"Marasco Dominic","position":1,"cik":"0002053897","reported_name":"Marasco Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2026-05-23T00:48:42.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":8474,"price":2.95,"value":24998.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 29, 2018. The purchase was approved by the Company's Board of Directors on May 20, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,343 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2025."}],"balance_after":344246,"source":{"system":"sec-edgar","filing":"0001193125-26-237428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000119312526237428/ownership.xml","form_type":"4"}},{"id":1102043,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":29916,"kind":"person","name":"Marasco Dominic","position":1,"cik":"0002053897","reported_name":"Marasco Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Endocrine Business Unit"}}],"security":"Performance Restricted Stock Unit","published_at":"2025-06-26T01:00:08.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%."}],"balance_after":1000000,"derivative":{"underlying":"Common Stock, $0.01 Par Value","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000950170-25-090116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017025090116/ownership.xml","form_type":"4"}},{"id":1146276,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":29916,"kind":"person","name":"Marasco Dominic","position":1,"cik":"0002053897","reported_name":"Marasco Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Endocrine Business Unit"}}],"security":"Performance Restricted Stock Unit","published_at":"2025-05-16T22:20:27.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":72500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The performance-based restricted stock unit will vest on July 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2025 until June 30, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The performance-based restricted stock unit will vest on July 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2025 until June 30, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above."}],"balance_after":72500,"derivative":{"underlying":"Common Stock, $0.01 Par Value","underlying_shares":72500},"source":{"system":"sec-edgar","filing":"0000950170-25-073800","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017025073800/ownership.xml","form_type":"4"}},{"id":1146275,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":29916,"kind":"person","name":"Marasco Dominic","position":1,"cik":"0002053897","reported_name":"Marasco Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2025-05-16T22:20:27.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":21929,"price":4.56,"value":99996.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on May 14, 2025."}],"balance_after":333429,"source":{"system":"sec-edgar","filing":"0000950170-25-073800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017025073800/ownership.xml","form_type":"4"}},{"id":1146274,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":29916,"kind":"person","name":"Marasco Dominic","position":1,"cik":"0002053897","reported_name":"Marasco Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2025-05-16T22:20:27.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":59500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to a Restricted Stock Unit Award: 25% vest on July 15, 2026 and each yearly anniversary thereof until fully vested. Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."}],"balance_after":311500,"source":{"system":"sec-edgar","filing":"0000950170-25-073800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017025073800/ownership.xml","form_type":"4"}},{"id":1270309,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":29916,"kind":"person","name":"Marasco Dominic","position":1,"cik":"0002053897","reported_name":"Marasco Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2025-02-14T02:30:04.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Four-year vesting schedule with no shares vesting on the first anniversary of the vesting determination date of January 6, 2025 and one-third on each anniversary thereafter until fully vested on the fourth anniversary of the vesting determination date."}],"balance_after":252000,"source":{"system":"sec-edgar","filing":"0000950170-25-020295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017025020295/ownership.xml","form_type":"4"}}]}